Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > SVA, SPEC BUY, PT $3.25 Potential 100% increase.

<< Previous

Bullboard Posts

Next >>

Comment by elgin1on Feb 12, 2022 1:37am

232 Views

Post# 34422761

RE:SVA, SPEC BUY, PT $3.25 Potential 100% increase.

rixpix wrote: Echelon commenced coverage with a spec buy and a $3.25 P.T. I can live with that. :))

Ripper,

That was already posted a few days ago . Wally originslly posted it before anyone and it was posted on the blog by Mercury I believe so don't get too excited .

The market is going to crash here in the next few weeks , taking everything down with it. Might be like the 87 crash.

MS

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario